Remarkably, however, the CD44+α2β1+ LAPC9 cells, unlike CD44+α2β1+ Du145 cells, demonstrated > 900 fold enrichment in tumor-initiating capacity compared to the double-negative cells (Table 2). Here, CD44 is linked to neoplasm.